Skip to main content
CNC logo

CNC · Centene Corp

Track CNC — free
$65.47 +0.47 (+0.72%) At close · Aug 26
Market Cap
$32.11B
Shares
494.00M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$65.47 Open$65.00 Day$64.98–67.68 52W close$28.38–68.72 Avg vol 30d4.6M Short int13.3M · 2.7% float · 3.0d Short vol40% Last earningsOct 27, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 28

Up next

Next earnings call
Oct 27, 2026 Scheduled · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 28, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol High
      Market backdrop VIX 15.2 · calm Equity put/call 0.64
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +33%
      above
      Price vs 50-day avg +1%
      above
      RSI (14) 51
      neutral
      MACD trend Negative
      52-week position 92%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +6%
      trailing
      6-month return +51%
      trailing
      YTD return +59%
      this year
      Relative strength +39%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $65 › 200d $49 — 50d above 200d
      Institutional flow Accumulating
      +15% holders QoQ · +223 funds added
      Insider flow Distributing
      Net -$8.3M over 90 days · 100% sells
      Short interest Falling
      2.69% of float · ▼ -2.4% MoM · 3.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      1,003 holders — near 3-yr high, broad support
      Squeeze score 53
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +19%
      Y/Y
      Gross margin 7%
      contracting
      EPS growth −314%
      Y/Y
      Free cash flow $4.3B
      Buyback $1.8B
      remaining
      Balance sheet $487.0M
      net cash
      Quant / Vol
      risk profile
      High
      Volatility 49%
      annualized · 1-yr
      Max drawdown −33%
      past year
      ATR 3.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 1 of last 3
      Latest guidance · from the 8-K filed Apr 28, 2026
      GAAP diluted EPS · full year 2026 at least $2.37
      Adjusted diluted EPS · full year 2026 at least $3.40
      Prior guidance period ended · from the 8-K filed Oct 29, 2025
      GAAP diluted loss per share · full year 2025 at least $-12.85
      Guided vs delivered · last 3 settled
      GAAP diluted loss per share full year 2025
      guided at least $-12.85
      $-13.53 Miss −5.3%
      Premium and service revenue full year 2023
      guided $136B
      $154B Beat +13.2%
      At least $7.15 of EPS 2024
      guided at least $7.15
      $6.31 Miss −11.7%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +33% Bullish
      Price vs 50-day avg
      +1% Bullish
      RSI (14)
      51 Neutral
      MACD trend
      Negative Bearish
      52-week position
      92% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $65 › 200d $49 — 50d above 200d
      Institutional flow Accumulating
      +15% holders QoQ · +223 funds added
      Insider flow Distributing
      Net -$8.3M over 90 days · 100% sells
      Short interest Falling
      2.69% of float · ▼ -2.4% MoM · 3.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      1,003 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $28 Now $65 · 92% Range high $69
      vs 200-day avg +33% vs 50-day avg +1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Commercial HBR 77.2% Six Months Ended June 30, 2026
      High Acuity Medicaid 1,364,900 Q2 2026
      Individual and Commercial Group 497,000 Q2 2026
      Medicaid HBR 93.5% Six Months Ended June 30, 2026
      Medicare HBR 87.3% Six Months Ended June 30, 2026
      Medicare segment HBR 89.5% Q2 2026
      Regulated cash, investments and restricted deposits $43.02B Q2 2026
      Total cash, investments and restricted deposits $44.85B Q2 2026
      Traditional Medicaid 10,745,800 Q2 2026
      Unregulated cash, investments and restricted deposits $1.83B Q2 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Healthcare Plans — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CNC
      Centene Corp
      this stock
      $32.11B +59.1% +19.4% 2.7%
      UNH
      Unitedhealth Group Inc
      $357.92B +21.5% +11.8% 1.7%
      CVS
      CVS HEALTH Corp
      $118.82B +18.9% +7.8% 24.5 1.3%
      ELV
      Elevance Health, Inc.
      $86.50B +14.8% +12.5% 17.7 2.5%
      CI
      Cigna Group
      $73.81B +2.0% +11.2% 11.6 2.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      1,003
      % held
      101.9%
      Net QoQ
      +8.8M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      821
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      13.3M
      Days to cover
      3.0d
      Change
      -320.0K sh
      View
      Short Volume
      Short vol %
      40%
      As of
      Aug 26, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      4.8K
      Value
      $289.8K
      As of
      Jul 31, 2026
      View
      Off-Exchange
      Off-exchange %
      41.0%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$8.3M
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Tim Moore
      Amount
      $100.0K–$250.0K
      Traded
      Aug 18, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $194.8B
      Net income (FY)
      $-6.7B
      EPS diluted
      $-13.53
      View
      Buybacks
      Authorized
      $10.0B
      Remaining
      $1.8B
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 17, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $2.8M
      Shares
      43.6K
      Filed
      Aug 26, 2026
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Oct 27, 2026
      Last call
      Jul 28, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      CNC +1.2% +5.9% +51.3% +5.2% +59.1%
      SPY -0.4% +5.0% +12.4% +2.6% +12.3%
      vs SPY +1.6% +0.9% +38.9% +2.7% +46.8%

      Capital returns

      Buyback program · as of Jun 30, 2026
      Authorized
      $10.00B
      Spent (derived)
      $8.20B
      Remaining
      $1.80B
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1071739 CUSIP 15135B101 13F (30d) 753 filings 749 filers Visit website Investor relations